Michael H. Davidson is clinical professor and director of preventive cardiology at the University of Chicago. He is also consulting chief medical officer for Omthera Pharmaceuticals. Davidson earned his medical degree from the Ohio State University College of Medicine in Columbus. He then completed his residency and fellowship in cardiology at Rush University Medical Center in Chicago.
An active researcher, Davidson’s clinical research background encompasses both pharmaceutical and nutritional clinical trials. His extensive research on statins, novel lipid-lowering drugs, and nonpharmacologic risk factor reduction has established him as a key opinion leader in this area. A prolific author and lecturer on lipid disorders, nutrition, and atherosclerosis, Davidson has coordinated more than 1,000 clinical trials in areas of preventive cardiology and published more than 250 articles for leading medical journals; he has also written three books on lipidology.
Davidson is board-certified in internal medicine, cardiology, and clinical lipidology. He is a Fellow of the American College of Cardiology and the American College of Chest Physicians and president (2010-2011) of the National Lipid Association. He was listed in The Best Doctors in America for the past 10 years and was named Father of the Year by the American Diabetes Association in 2010.